Case Study: Merz Therapeutics achieves faster portfolio expansion with ITONICS competitive intelligence

How Merz Therapeutics is expanding its product portfolio using a tech scouting platform

Merz Therapeutics, part of the Merz Group, wanted to accelerate portfolio expansion and strengthen competitive intelligence as chronic disease demand rose, patents expired, and competition intensified. Its R&D, tech scouting, marketing, and corporate development teams had been working in silos with no single source of truth, and Excel-based tracking created heavy workloads and data loss. Since 2018, the company has used ITONICS’ innovation platform to support technology scouting and external innovation.

ITONICS implemented a centralized scouting process that collects and evaluates data on 400+ companies, 800+ products, 300+ patents/publications/news items, and 170+ clinical trials, enriched by AI-enabled signals feeds and shared across departments and external partners. The result is a single point of truth that makes competitive intelligence easier to search, filter, and visualize, improves collaboration, and helps Merz Therapeutics identify emerging technologies and business opportunities faster. This has enabled more traceable decision-making on partnerships, due diligence, and portfolio expansion, with plans to roll the platform out to even more teams.

Merz Therapeutics

Iris Manneck

Head of Corporate Development/ M&A